Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × avelumab × Clear all

NCT03312114 2020-11-12

Anti-PD-L1 and SAbR for Ovarian Cancer

Phase 2 Terminated

5 enrolled 4 charts

Fallopian Tube Neoplasms